NCT06426992Recruiting
Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
Evaluation of Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Small Liver Malignancies: A Prospective Single Center Study
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The purpose of this study is to determine the technical success rate of creating a safety margin of 5 mm or more including the tumor by performing image-guided percutaneous microwave thermal therapy using a microwave generator and antenna developed by StarMed for the treatment of small liver cancer and the 1-year local recurrence rate based on follow-up imaging tests.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- First submitted
- 19 May 2024
- Start date
- Apr 2024
- Primary completion date
- Aug 2026
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06426992
What you commit to
- Study type: Interventional
- Planned participants: 128
- From Apr 2024 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- In cases where there are three or more malignant liver tumors
- Diffuse infiltrative type of cancer with unclear tumor boundaries
- Severe liver failure (Child-Pugh Class C)
- In cases of vascular invasion by malignant liver tumors
Lab values
- Severe coagulopathy (platelet count below 50,000/mm³ or INR prolonged by more than 50%)
Other
- When the maximum size of the tumor exceeds 4 cm
- When the tumor is adhered to the central hepatic portal vein, hepatic vein, or bile duct by 5 mm or more
- In cases of multiple extrahepatic metastases
- Situations where it is highly unlikely to obtain appropriate data for research purposes
Who the study is looking for
- Child-Pugh Class A or B
- Patients with suspected hepatocellular carcinoma or residual/recurrent hepatocellular carcinoma of 4 cm or less on MDCT, CEUS, or MRI performed within the last 60 days or Patients with suspected metastatic liver cancer of 4 cm or less on MDCT, CEUS, or MRI performed within the last 60 days, for whom microwave thermal ablation is being considered
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.